axiVEND Company Profile

Background

Overview

axiVEND, founded in 2019, specializes in providing instruments and services for the development and production of microarrays, biosensors, and biochips. The company is headquartered in Winter Garden, Florida, and operates within the biotechnology and life sciences sectors. axiVEND's mission is to deliver high-quality solutions for diagnostics, environmental testing, and multiplex assays, emphasizing precision and reliability.

Mission and Vision

axiVEND is committed to offering state-of-the-art technologies and services that facilitate the creation of microarrays and biosensors. Their vision is to be a trusted partner in advancing diagnostics and environmental monitoring through innovative and effective solutions.

Primary Area of Focus

The company's primary focus includes:

Microarray Spotting and Reading Instruments: Providing equipment for the precise deposition and analysis of microarrays.

Label-Free Detection Technology: Offering systems that enable real-time monitoring of biomolecular interactions without the need for labeling.

Contract Device Development and Manufacturing Services: Assisting clients in developing and manufacturing custom devices tailored to specific applications.

Industry Significance

axiVEND plays a crucial role in the biotechnology and life sciences industries by supplying essential tools and services that support the development of diagnostic tests, environmental monitoring systems, and research applications. Their contributions enhance the efficiency and accuracy of multiplex testing, benefiting sectors such as healthcare, food safety, and environmental science.

Key Strategic Focus

Core Objectives

axiVEND aims to:

Advance Diagnostic Capabilities: By providing innovative tools for multiplex testing, they support the rapid and accurate detection of various pathogens and contaminants.

Enhance Environmental Monitoring: Through their biosensor technologies, they contribute to the monitoring of air and water quality, ensuring public health and safety.

Support Research and Development: By offering contract services and customizable solutions, they assist organizations in developing new assays and diagnostic tests.

Specific Areas of Specialization

axiVEND specializes in:

Microarray Technology: Supplying instruments and consumables for the creation and analysis of microarrays.

Biosensor Development: Providing technologies for the development of sensors used in diagnostics and environmental testing.

Multiplex Testing Solutions: Offering systems that enable the simultaneous detection of multiple analytes, improving testing efficiency and throughput.

Key Technologies Utilized

The company employs:

M2-Automation Spotters: For ultra-low volume, high-precision liquid deposition.

Colorimetric and Fluorescence Array Readers: For the analysis of microarrays.

Label-Free Detection Systems: Such as the MX-100 from iRiS Kinetics, enabling real-time monitoring of biomolecular interactions.

Primary Markets Targeted

axiVEND serves markets including:

Diagnostics: Providing tools for the development of diagnostic tests.

Environmental Testing: Supplying sensors for monitoring environmental parameters.

Food Safety: Offering solutions for detecting contaminants in food products.

Financials and Funding

Funding History

Specific details regarding axiVEND's total funds raised and recent funding rounds are not publicly disclosed. The company has been privately held since its inception in 2019.

Notable Investors

Information about individual investors or venture capital firms involved with axiVEND is not publicly available.

Utilization of Capital

While specific utilization details are not disclosed, it is likely that the capital has been used to:

Expand Product Development: Enhancing existing products and developing new technologies.

Increase Manufacturing Capabilities: Scaling up production to meet market demand.

Support Research and Development: Investing in R&D to drive innovation.

Pipeline Development

Key Pipeline Candidates

axiVEND's pipeline includes:

Multiplex Testing Products: Developing assays for the detection of multiple pathogens and contaminants in a single test.

Biosensor Technologies: Advancing sensors for environmental monitoring and diagnostics.

Stages of Development

The company is involved in various stages of development, from initial R&D to product commercialization. For example, their collaboration with GENSPEED Biotech focuses on the production of novel multiplex tests for the food and environmental testing industries.

Target Conditions

The company's products aim to detect a range of conditions, including:

Pathogens: Such as bacteria and viruses.

Contaminants: Including pesticides and other harmful substances.

Anticipated Milestones

While specific timelines are not publicly disclosed, axiVEND is expected to achieve milestones related to:

Product Launches: Introducing new assays and sensor technologies to the market.

Regulatory Approvals: Obtaining necessary certifications for their products.

Technological Platform and Innovation

Proprietary Technologies

axiVEND's proprietary technologies include:

M2-Automation Spotters: For precise liquid deposition in microarray creation.

Label-Free Detection Systems: Such as the MX-100, enabling real-time monitoring of biomolecular interactions.

Significant Scientific Methods

The company utilizes:

Interferometric Reflectance Imaging Sensor (IRIS) Technology: For label-free detection of biomolecular interactions.

Microfluidics: In the development of biosensors and diagnostic tests.

AI-Driven Capabilities

While specific AI-driven capabilities are not detailed, axiVEND's focus on advanced detection technologies suggests potential applications of AI in data analysis and assay development.

Leadership Team

Key Executives

Claude Dufresne, PhD: CEO of axiVEND. Dr. Dufresne has a background in pharmaceutical R&D and has held leadership roles in business development and commercialization.

Selim Ünlü: Founder and CEO of iRiS Kinetics. Dr. Ünlü specializes in label-free detection technologies and has a background in biomedical engineering.

Leadership Changes

No significant leadership changes have been publicly reported.

Competitor Profile

Market Insights and Dynamics

The market for microarray and biosensor technologies is growing, driven by increasing demand for rapid and accurate diagnostic tests, environmental monitoring, and food safety assessments. Advancements in multiplex testing and label-free detection methods are key trends shaping the industry.

Competitor Analysis

axiVEND's competitors include:

GENSPEED Biotech: Specializes in rapid testing solutions based on microfluidics and opto-electronics.

iRiS Kinetics: Focuses on label-free detection systems for biomolecular interactions.

M24You GmbH: Provides low-volume liquid handling technology for microarrays and biosensors.

Strategic Collaborations and Partnerships

axiVEND has formed several strategic partnerships, including:

GENSPEED Biotech: Collaborating on the production of novel multiplex tests for the food and environmental testing industries.

iRiS Kinetics: Expanding their partnership to commercialize label-free detection systems.

Let's Go Robotics: Exclusive distribution agreement for Precise Drop II and BioRaptr 2.0 products in the U.S.

Operational Insights

axiVEND's collaborations enhance its product offerings and market reach, positioning the company to effectively compete in the biotechnology sector.

axivend